Vaccines should be easily accessible to every person on earth!

uPRAX aims to accelerate the transition of microneedles from a research environment into real world, lifesaving solutions. With a size of less than 1 mm, they have proved to be more effective and less intrusive compared to many conventional methods of drug administration; great breakthrough innovations are being achieved around the world every day. Design and engineering of the actual application procedure for end users is now begging for attention.

How far would you go to save a life? We'd go less than 1 mm.

Microneedles are, without a doubt, the drug administrative tool of the future. Their size reduces pain and chances for infections, while simultaneously removing the need for in demand doctors.

Many drugs work most efficiently when administered into the skin and the costly distribution channel (cold chain) associated with conventional vaccines can potentially be removed.

What We Do

Our team is built on a decade of experience in applying microneedle technologies, as well as bringing medical innovations to the forefront of the industry. We are now expanding into the development and production of end-user microneedle applications based on the knowledge and IP we’ve generated ourselves, and by collaborating with others.


To advance the microneedle field as a whole, uPRAX also offers custom R&D solutions and quality research tools to extract samples, deliver drugs, and administer vaccines via the skin.

End-user Applications

Creating life saving products for specific drug delivery purposes.

We offer R&D services and our specialty is microneedle application.

Research Applicators

Consistent application of microneedles in a research environment.

Are you passionate about the potential of microneedles too?

We would love to hear from you!


The natural progression of microneedle technologies requires collaboration between any and all practitioners. Together we can bring microneedles to the masses and make it an industry standard!


Don’t hesitate to contact us with any questions – if we can’t answer them ourselves, we might be able to connect you with somebody else we’ve been talking to.

Latest news

Nothing found.